Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.124 AUD
−47.95 M AUD
299.23 K AUD
1.91 B
About RADIOPHARM THERANOSTICS LIMITED
Sector
Industry
CEO
Riccardo Canevari
Website
Headquarters
Carlton
Founded
2021
ISIN
AU0000181851
FIGI
BBG0132XC5K0
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RAD is 0.024 AUD — it has increased by 14.29% in the past 24 hours. Watch RADIOPHARM THERANOSTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange RADIOPHARM THERANOSTICS LIMITED stocks are traded under the ticker RAD.
RAD stock has fallen by −14.29% compared to the previous week, the month change is a −11.11% fall, over the last year RADIOPHARM THERANOSTICS LIMITED has showed a −66.20% decrease.
We've gathered analysts' opinions on RADIOPHARM THERANOSTICS LIMITED future price: according to them, RAD price has a max estimate of 0.40 AUD and a min estimate of 0.40 AUD. Watch RAD chart and read a more detailed RADIOPHARM THERANOSTICS LIMITED stock forecast: see what analysts think of RADIOPHARM THERANOSTICS LIMITED and suggest that you do with its stocks.
RAD stock is 21.74% volatile and has beta coefficient of 1.37. Track RADIOPHARM THERANOSTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is RADIOPHARM THERANOSTICS LIMITED there?
Today RADIOPHARM THERANOSTICS LIMITED has the market capitalization of 52.15 M, it has decreased by −13.33% over the last week.
Yes, you can track RADIOPHARM THERANOSTICS LIMITED financials in yearly and quarterly reports right on TradingView.
RADIOPHARM THERANOSTICS LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
RAD net income for the last half-year is −23.19 M AUD, while the previous report showed −24.76 M AUD of net income which accounts for 6.33% change. Track more RADIOPHARM THERANOSTICS LIMITED financial stats to get the full picture.
No, RAD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RADIOPHARM THERANOSTICS LIMITED EBITDA is −35.35 M AUD, and current EBITDA margin is −11.81 K%. See more stats in RADIOPHARM THERANOSTICS LIMITED financial statements.
Like other stocks, RAD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RADIOPHARM THERANOSTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RADIOPHARM THERANOSTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RADIOPHARM THERANOSTICS LIMITED stock shows the sell signal. See more of RADIOPHARM THERANOSTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.